PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2011 2012 2013 2014 2015 2016
AMREF is a district-based partner aiming to improve the health status of rural populations by reducing new HIV infections through scaling up VMMC services, improving the diagnosis and treatment of sexually transmitted infections (STI) and sustaining active linkages to other HIV prevention services. AMREF is funded in FY 2012 to implement VMMC at government-owned public health facilities with community outreach activities and through stand-alone sites and/or mobile surgical camps using dedicated VMMC teams. In FY 2012, AMREF is not funded for sexual/behavioral risk reduction that focuses on abstinence and being faithful nor for condom provision and other prevention. AMREF operates in seven rural districts with high HIV prevalence of 8% and above - Wakiso, Mubende, Mityana, Luweero, Nakaseke, Nakasongola, as well as, Kalangala district with one of the largest fishing communities of Lake Victoria with very high HIV prevalence estimated at 22%. In FY 2012, AMREF will offer VMMC to 75,331 eligible adult males. AMREF will track and monitor the progress and achievements in VMMC and STI treatment including the processes and outputs at district and community levels and report daily to the VMMC National Operational Center approved by the MOH. AMREF has requested to purchase two vehicles and one boat (with two outboard engines) with carryover funds.
Five vehicles purchased under this mechanism in FY 2012. AMREF would like to purchase two more vehicles in FY 2013, therefore, over the life of this mechanism they will purchase seven in total. To facilitate coordination of VMMC scale up activities in seven districts at static health facilities and mobile outreaches/camps with intense monitoring activities for quality assurance and support supervision to field teams.
AMREF will scale up VMMC services through multiple approaches to contribute to Ugandas national target of 1 million male circumcision procedures in 2012/2013. The target population is adolescent males and adult men who are likely to be sexually active and are at high risk of acquiring HIV including most-at-risk populations (MARPS), youth in and out of school, and male sero-discordant partners of HIV-positive females. In FY 2011 AMREF accomplished 67,733 circumcisions against a target of 30,000. The FY 2012 target is 75,331 circumcisions. VMMC services will be delivered through 65-70 dedicated teams with a district distribution estimated as follows: Wakiso-20 teams; Luweero-10 teams; Kalangala-six teams; Nakaseke-six teams; Nakasongola-six teams; Mityana-six teams; and Mubende-nine teams. Through these teams AMREF will conduct between 40-55 community outreaches and mobile and/or surgical camps per month at stand-alone sites during FY 2012. There will be integrated VMMC services within 48 public health facilities (hospitals, health centers, and regional referral hospitals) using a modified MOVE model. To increase demand for VMMC for HIV prevention, AMREF will concentrate on community mobilization approaches targeting in-school youth (15-18 years); males in tertiary institutions (18-25 years); and the general population (15+ years). The communication strategies for mobilization will involve meetings with community and opinion leaders at key cultural, religious, and social festivities, as well as, through utilization of peer-model linkages (involving already circumcised males) to pass on communication (including MOH brochures/materials) about the availability of VMMC services. At the health center, AMREF will support health education sessions targeted at men and women visiting out-patient departments including STI clinics. To maximize the identification of eligible adult males, AMREF will exploit potential and actual linkages across other program areas. AMREF will offer HIV testing and counseling to consenting eligible males and then provide VMMC to those who consent to undergo circumcision. In addition, AMREF will offer STI screening, and anyone with a positive diagnosis for an STI will be treated while HIV negative males will be offered VMMC after completing treatment. AMREF will work with the External Quality Assurance team formed under the auspices of the National SMC Task Force in the MOH as needed.
